Fibroblasts from COPD patients are less capable of sustaining tissue repair, which may be due to decreased synthesis and deposition of extracellular matrix (ECM) components, as well as decreased sensitivity to TGF-β1 [106]. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.